Member Company

Nooxbio, Inc.

Nooxbio Inc. is a pioneer in digital therapeutics based in South Korea. We exist to address unmet needs within the realm of mental healthcare. Our psychiatrists, who dedicated their work in brain science, have taken traditional neurocognitive tests and digitized them. Our computerized neurocognitive test battery comprises a number of individual game modules – each designed to test a specific area of cognition. In our pipeline, we also have several digital therapeutics in development to address unmet needs within most prevalent mental illnesses. Our digital therapeutics offer AI powered CBT; this allows our solutions to provide more personalized support to the patients as well as to remove barriers of communication throughout their treatment journey. We are a team of experts with strong backgrounds in both brain science and biopharmaceutical. Based on our combined experiences in drug development and clinical research on brain science, we have the confidence to build digital therapeutics with proven efficacy.

Copyright © 2022 Digital Therapeutics Alliance™